Overall | 10 289 | 161 874 | 1600 | | | 1950 | | |
NTM-PD diagnosis at 6-months or later | 5198 | 161 874 | | | | 978 | | |
Sex |
Females | 7972 (77.5) | 102 946 (63.6) | 1880 | 1.81 | 1.72–1.91 | 2260 | 1.73 | 1.65–1.81 |
Males | 2317 (22.5) | 58 928 (36.4) | 1040 | | | 1310 | | |
Age category |
65–69 years | 2275 (22.1) | 32 696 (20.2) | 1540 | | | 1910 | | |
70–74 years | 2407 (23.4) | 38 010 (23.5) | 1520 | 0.99 | 0.92–1.05 | 1850 | 0.97 | 0.91–1.02 |
75–79 years | 2447 (23.8) | 36 515 (22.5) | 1620 | 1.05 | 0.98–1.12 | 1970 | 1.03 | 0.98–1.10 |
≥80 years | 3160 (30.7) | 54 653 (33.8) | 1690 | 1.09 | 1.03–1.16 | 2000 | 1.05 | 0.99–1.11 |
COPD diagnosis |
COPD | 3935 (38.2) | 84 072 (51.9) | 1250 | 0.58 | 0.56–0.61 | 1570 | 0.62 | 0.60–0.64 |
No COPD | 6354 (61.8) | 77 802 (48.1) | 2150 | | | 2540 | | |
Race and ethnicity |
American Indian or Alaska native | 15 (0.1) | 611 (0.4) | 767 | 0.46 | 0.25–0.77 | 822 | 0.41 | 0.23–0.67 |
Asian/Pacific Islander | 544 (5.3) | 6296 (3.9) | 2037 | 1.22 | 1.10–1.34 | 2507 | 1.24 | 1.14–1.35 |
Black | 211 (2.1) | 8046 (4.9) | 705 | 0.42 | 0.36–0.49 | 846 | 0.42 | 0.36–0.48 |
Hispanic | 408 (4.0) | 9607 (5.9) | 985 | 0.59 | 0.52–0.66 | 1284 | 0.64 | 0.57–0.70 |
Other | 84 (0.8) | 1231 (0.8) | 1731 | 1.04 | 0.81–1.32 | 2048 | 1.01 | 0.81–1.26 |
Unknown | 15 (0.1) | 327 (0.2) | 1551 | 0.93 | 0.46–1.66 | 2115 | 1.05 | 0.59–1.73 |
White (non-Hispanic) | 9012 (87.6) | 135,757 (83.9) | 1671 | | | 2018 | | |
Baseline patient characteristics |
Comorbidities§,ƒ |
Allergic bronchopulmonary aspergillosis | 56 (0.5) | 726 (0.5) | | | | | | |
Alpha-1 antitrypsin deficiency | 18 (0.2) | 335 (0.2) | | | | | | |
Asthma | 2189 (21.3) | 46 581 (28.8) | | | | | | |
Interstitial lung disease | 234 (2.3) | 7765 (4.8) | | | | | | |
Lung cancer | 286 (2.8) | 5990 (3.7) | | | | | | |
Primary ciliary dyskinesia | 9 (0.1) | 113 (0.1) | | | | | | |
Primary immune deficiency | 324 (3.1) | 4537 (2.8) | | | | | | |
Pseudomonas infection | 336 (3.3) | 5601 (3.5) | | | | | | |
Rheumatoid arthritis | 365 (3.5) | 7301 (4.5) | | | | | | |
Silicosis | 8 (0.1) | 194 (0.1) | | | | | | |
Baseline§,ƒ medication use |
Home oxygen therapy prescription | 1168 (11.4) | 39 429 (24.4) | | | | | | |
Inhaled antibiotic prescription | 76 (0.7) | 1350 (0.8) | | | | | | |
ICS | 582 (5.6) | 11 158 (6.9) | | | | | | |
Corticosteroids | 2251 (21.9) | 50 248 (31.0) | | | | | | |
Nebuliser use | 1571 (15.3) | 40 967 (25.3) | | | | | | |